Grant Castor | Chief Business & Commercial Officer
Sentynl Therapeutics
Grant has nearly two decades of commercial, business development, finance, and operations experience in the biopharma and medical device industry. Prior to joining the Sentynl team in 2015, Grant led marketing operations for Amedra Pharmaceuticals and Lineage Therapeutics, which was successfully sold to Impax Laboratories in 2015. Before entering the biopharmaceutical industry Grant held numerous commercial roles in the Medical Device sector; most notably as the head of US operations and global marketing for an Israel-based organization, where they successfully commercialized a novel orthopedic device in over 30 countries. He holds his BS in International Business from Johnson & Wales University.
Appearances:
Day 1 - World Orphan Drug Congress USA 2026 @ 15:30
Rare Launch Readiness: Building the Foundation for Commercial Success
As rare disease therapies move from development to commercialization, companies face a uniquely complex launch landscape—small, geographically dispersed patient populations, nuanced clinical value communication, limited real-world data, and the need for deep trust with patient communities. This panel brings together commercial leaders, market access strategists, and patient-focused experts to explore what it truly takes to build a launch-ready organization in the rare disease space.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events